Trials / Completed
CompletedNCT05674318
The Effect of Alpha-lactalbumin on Microbiota Composition
Evaluation of Prebiotic Effects of Alpha-lactalbumin on Microbiota Composition
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Lo.Li.Pharma s.r.l · Industry
- Sex
- All
- Age
- 25 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the effects on microbiota composition after the administration of an oral supplementation based on Alpha-lactalbumin in subjects with dysbiosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Alpha-lactalbumin | Oral assumption of two tabs/day containing Alpha-lactalbumin for 30 days |
Timeline
- Start date
- 2023-01-30
- Primary completion
- 2023-09-30
- Completion
- 2023-11-30
- First posted
- 2023-01-06
- Last updated
- 2024-02-20
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT05674318. Inclusion in this directory is not an endorsement.